BPG is committed to discovery and dissemination of knowledge
Featured Articles
9/8/2023 9:45:24 AM | Browse: 455 | Download: 1048
 |
Received |
|
2023-05-25 04:37 |
|
Peer-Review Started |
|
2023-05-25 04:38 |
|
First Decision by Editorial Office Director |
|
2023-06-15 09:16 |
|
Return for Revision |
|
2023-06-15 09:16 |
|
Revised |
|
2023-07-24 12:40 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2023-08-18 02:38 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2023-08-18 09:04 |
|
Articles in Press |
|
2023-08-18 09:04 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-08-23 07:00 |
|
Publish the Manuscript Online |
|
2023-09-08 09:38 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Hematology |
| Manuscript Type |
Case Report |
| Article Title |
T/myeloid mixed-phenotype acute leukemia treated with venetoclax and decitabine: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Sungwoo Park, Eun Jeong Jeong, Jung Hun Kang, Gyeong-Won Lee, Se-Il Go, Dong-Hyun Lee and Eun-Ha Koh |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Gyeong-Won Lee, MD, PhD, Associate Professor, Division of Hematology and Oncology, Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Jinju 52727, South Korea. brightree@naver.com |
| Key Words |
Mixed-phenotype acute leukemia; Venetoclax; Decitabine; Case report |
| Core Tip |
We report a 55-year-old male diagnosed with T/myeloid mixed-phenotype acute leukemia (MPAL) who received induction chemotherapy with vincristine, prednisolone, daunorubicin, and L-asparaginase. The patient experienced septic shock 10 days post-induction therapy and received antibiotic therapy to treat extended-spectrum beta-lactamase-positive bacteremia. Bone marrow examination post-sepsis recovery revealed refractory disease. To reduce the infection risk, venetoclax and decitabine were administered as chemotherapy-free induction therapy. After two additional venetoclax/decitabine cycles, the patient underwent haploidentical peripheral blood stem-cell transplantation, subsequently achieving complete response. This is the third report documenting the successful treatment of refractory T/myeloid MPAL with venetoclax and a hypomethylating agent. |
| Publish Date |
2023-09-08 09:38 |
| Citation |
Park S, Jeong EJ, Kang JH, Lee GW, Go SI, Lee DH, Koh EH. T/myeloid mixed-phenotype acute leukemia treated with venetoclax and decitabine: A case report. World J Clin Cases 2023; 11(26): 6200-6205 |
| URL |
https://www.wjgnet.com/2307-8960/full/v11/i26/6200.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v11.i26.6200 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
